Eric Ho Man Tang

684 total citations
35 papers, 428 citations indexed

About

Eric Ho Man Tang is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Surgery. According to data from OpenAlex, Eric Ho Man Tang has authored 35 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Epidemiology and 6 papers in Surgery. Recurrent topics in Eric Ho Man Tang's work include Diabetes Treatment and Management (11 papers), Diabetes Management and Research (6 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers). Eric Ho Man Tang is often cited by papers focused on Diabetes Treatment and Management (11 papers), Diabetes Management and Research (6 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers). Eric Ho Man Tang collaborates with scholars based in Hong Kong, China and United Kingdom. Eric Ho Man Tang's co-authors include Carlos King Ho Wong, Cindy Lo Kuen Lam, Janet Yuen Ha Wong, Abraham Ka Chung Wai, Ivan Chi Ho Au, Yu Cho Woo, Eric Yuk Fai Wan, Dyt Fong, Laura Elizabeth Bedford and Chi‐Ho Lee and has published in prestigious journals such as Hepatology, Diabetes Care and Annals of Surgery.

In The Last Decade

Eric Ho Man Tang

34 papers receiving 422 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Ho Man Tang Hong Kong 13 156 59 58 56 55 35 428
Venexia Walker United Kingdom 15 104 0.7× 112 1.9× 84 1.4× 131 2.3× 90 1.6× 36 717
Ji In Park South Korea 17 87 0.6× 69 1.2× 86 1.5× 87 1.6× 30 0.5× 60 858
Shengsheng Yu United States 12 166 1.1× 22 0.4× 94 1.6× 60 1.1× 14 0.3× 21 404
Erica A. Voss United States 11 48 0.3× 44 0.7× 75 1.3× 51 0.9× 23 0.4× 27 500
Mugdha Gokhale United States 14 117 0.8× 52 0.9× 56 1.0× 92 1.6× 14 0.3× 31 603
Emily Pfaff United States 15 63 0.4× 25 0.4× 50 0.9× 57 1.0× 69 1.3× 50 638
Nasrin Mansournia Iran 12 152 1.0× 43 0.7× 94 1.6× 48 0.9× 10 0.2× 28 480
Davood Shafie Iran 13 116 0.7× 249 4.2× 92 1.6× 67 1.2× 55 1.0× 66 592
Samuel Lendle United States 9 73 0.5× 24 0.4× 54 0.9× 25 0.4× 17 0.3× 14 365

Countries citing papers authored by Eric Ho Man Tang

Since Specialization
Citations

This map shows the geographic impact of Eric Ho Man Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Ho Man Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Ho Man Tang more than expected).

Fields of papers citing papers by Eric Ho Man Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Ho Man Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Ho Man Tang. The network helps show where Eric Ho Man Tang may publish in the future.

Co-authorship network of co-authors of Eric Ho Man Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Ho Man Tang. A scholar is included among the top collaborators of Eric Ho Man Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Ho Man Tang. Eric Ho Man Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Eric Ho Man, Ashraf A. Khan, & Steven L. Foley. (2025). Comparison of the Presence of Heavy Metal Resistance Genes in Salmonella enterica and Their Association with Antibiotic Resistance. Microorganisms. 13(12). 2696–2696.
2.
Fung, Matrix Man Him, Eric Ho Man Tang, Tingting Wu, et al.. (2025). Developing a named entity framework for thyroid cancer staging and risk level classification using large language models. npj Digital Medicine. 8(1). 134–134. 2 indexed citations
4.
Lui, David Tak Wai, Tingting Wu, Eric Ho Man Tang, et al.. (2023). Fracture risks associated with sodium-glucose cotransporter-2 inhibitors in type 2 diabetes patients across eGFR and albuminuria categories: A population-based study in Hong Kong. Diabetes Research and Clinical Practice. 197. 110576–110576. 7 indexed citations
5.
Tang, Eric Ho Man, Yu Cho Woo, Cindy Lo Kuen Lam, et al.. (2023). Psychometric properties of EQ-5D-5L for use in patients with Graves’ disease. Health and Quality of Life Outcomes. 21(1). 90–90. 4 indexed citations
7.
Lee, Chi‐Ho, Lung‐Yi Mak, Eric Ho Man Tang, et al.. (2023). SGLT2i reduces risk of developing HCC in patients with co-existing type 2 diabetes and hepatitis B infection: A territory-wide cohort study in Hong Kong. Hepatology. 78(5). 1569–1580. 16 indexed citations
8.
Lui, David Tak Wai, Eric Ho Man Tang, Ivan Chi Ho Au, et al.. (2022). Evaluation of Fracture Risk Among Patients With Type 2 Diabetes and Nonvalvular Atrial Fibrillation Receiving Different Oral Anticoagulants. Diabetes Care. 45(11). 2620–2627. 8 indexed citations
9.
Wong, Carlos King Ho, Kristy T. K. Lau, Eric Ho Man Tang, et al.. (2022). Cardiovascular benefits of SGLT2 inhibitors in type 2 diabetes, interaction with metformin and role of erythrocytosis: a self-controlled case series study. Cardiovascular Diabetology. 21(1). 92–92. 8 indexed citations
10.
Lui, David Tak Wai, Ivan Chi Ho Au, Eric Ho Man Tang, et al.. (2022). Kidney outcomes associated with sodium-glucose cotransporter 2 inhibitors versus glucagon-like peptide 1 receptor agonists: A real-world population-based analysis. EClinicalMedicine. 50. 101510–101510. 29 indexed citations
11.
Bedford, Laura Elizabeth, Eric Ho Man Tang, Carlos King Ho Wong, et al.. (2022). Who reports insufficient and disturbed sleep? Results from a representative population-based health survey in Hong Kong. BMJ Open. 12(9). e058169–e058169. 4 indexed citations
13.
Wu, Tingting, Carlos King Ho Wong, Eric Ho Man Tang, et al.. (2022). The comparative effects of metabolic surgery, SGLT2i, or GLP-1RA in patients with obesity and type 2 diabetes: a retrospective cohort study. Surgery for Obesity and Related Diseases. 18(6). 762–771. 2 indexed citations
14.
15.
Xiong, Xi, Abraham Ka Chung Wai, Janet Yuen Ha Wong, et al.. (2021). Impact of varying wave periods of COVID‐19 on in‐hospital mortality and length of stay for admission through emergency department: A territory‐wide observational cohort study. Influenza and Other Respiratory Viruses. 16(2). 193–203. 19 indexed citations
16.
Fong, Dyt, et al.. (2021). Generative adversarial networks for imputing missing data for big data clinical research. BMC Medical Research Methodology. 21(1). 78–78. 52 indexed citations
17.
Tang, Eric Ho Man, Carlos King Ho Wong, Laura Elizabeth Bedford, et al.. (2020). Trend in health-related quality of life and health utility and their decrements due to non-communicable diseases and risk factors: analysis of four population-based surveys between 1998 and 2015. Quality of Life Research. 29(11). 2921–2934. 4 indexed citations
18.
Wong, Carlos King Ho, Eric Ho Man Tang, Kenneth K. C. Man, et al.. (2020). SGLT2i as fourth-line therapy and risk of mortality, end-stage renal diseases and cardiovascular diseases in patients with type 2 diabetes mellitus. Diabetes & Metabolism. 47(4). 101196–101196. 10 indexed citations
19.
Wong, Carlos King Ho, Janet Yuen Ha Wong, Eric Ho Man Tang, Chun Hang Au, & Abraham Ka Chung Wai. (2020). Clinical presentations, laboratory and radiological findings, and treatments for 11,028 COVID-19 patients: a systematic review and meta-analysis. Scientific Reports. 10(1). 19765–19765. 45 indexed citations
20.
Lai, N. Chin, Mei Hua Gao, Eric Ho Man Tang, et al.. (2012). Pressure overload-induced cardiac remodeling and dysfunction in the absence of interleukin 6 in mice. Laboratory Investigation. 92(11). 1518–1526. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026